Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | ATM | Q13315 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23665832 | 0.94 | CYP3A4 (0.41) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL13955672 | 0.83 | TDP1 (0.34) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL18745551 | 0.80 | TDP1 (0.34) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL19750759 | 0.80 | TDP1 (0.34) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL13403927 | 0.79 | TDP1 (0.33) | CYP3A4ALDH1A1MAPK1TSHRTDP1 | |
| SCHEMBL13475567 | 0.78 | CYP3A4 (0.44) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL15244179 | 0.77 | CYP3A4 (0.45) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL22522159 | 0.77 | CYP3A4 (0.43) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL770794 | 0.77 | CYP3A4 (0.45) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 | |
| SCHEMBL23201542 | 0.77 | CYP3A4 (0.47) | CYP3A4L3MBTL1ALDH1A1CA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180090687-A1 | CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | IDEMITSU KOSAN CO., LTD (JP) | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180090687-A1 | CROSS-CONJUGATED POLYMER, MATERIAL FOR ELECTRONIC ELEMENT, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | SLC18A1, SLC1A2, SLC43A1 | CYP3A4 414/4885L3MBTL1 1552/4885ALDH1A1 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.